Peer-reviewedCC BYMedicine
Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer : Insights and outcomes
- 1Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 3Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Related
- PO125 | ROMIPLOSTIM FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN ADVANCED SOLID TUMORS: A SINGLE-CENTER EXPERIENCE
- COMBINED THERAPY WITH ELTROMBOPAG AND ROMIPLOSTIM IN IMMUNE THROMBOCYTOPENIA REFRACTORY TO MULTIPLE LINES OF THERAPY - A CASE SERIES
- Reconsidering the Diagnosis and Management of Obinutuzumab-induced Acute Thrombocytopenia
- Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial
- Persistent viral carriage of severe fever with thrombocytopenia syndrome virus in canine: A potential canine-to-human transmission event in a family cluster
BibTeX
@article{wang2026singlecenter,
title = {{Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer : Insights and outcomes}},
author = {Changjian Wang and Chuangyan Wu and Geng Wang and Kaiyue Wang and Shijiang Fei and Yan Zong and Xiaorong Dong and Sheng Zhang and Rui Zhou},
journal = {Medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657582},
note = {CC BY},
}
RIS
TY - JOUR
TI - Single-center experience with Romiplostim N01 for the management of severe persistent cancer therapy-induced thrombocytopenia in lung cancer : Insights and outcomes
AU - Changjian Wang
AU - Chuangyan Wu
AU - Geng Wang
AU - Kaiyue Wang
AU - Shijiang Fei
AU - Yan Zong
AU - Xiaorong Dong
AU - Sheng Zhang
AU - Rui Zhou
PY - 2026
DA - 2026/10/09
JO - Medicine
UR - https://europepmc.org/article/PMC/PMC13657582
SN - 0304-5412
SN - 1536-5964
ER -